Skip to main content
Have a personal or library account? Click to login
The Spectrum and Frequency of Cystic Fibrosis Mutations in Albanian Patients Cover

The Spectrum and Frequency of Cystic Fibrosis Mutations in Albanian Patients

By: ,  ,  ,   and    
Open Access
|Sep 2024

Figures & Tables

Table 1.

Incidence of Cystic fibrosis in Albania

Time PeriodBirth Rate in AlbaniaCF cases diagnosed at UHCMTIncidence
1992–201711441382851:4014
Table 2.

Overview data about patient with CF in Albania*

Year of follow up 2019Number (n=)Percentage (%)
No. of patients133100
Male7254.14
Female6145.86
  • Mean Age (years) at follow up.

  • (Min-max)

  • 10.5

  • 0.5–28.0

  • Mean Age (years) at diagnosis.

  • (Min-max)

  • 0.75

  • 0.0–16.0

No. of patients <18 years11586.47
No. of patients > 18 years1813.53
Homozygote for F508del8765.41
Compound heterozygous mutation F508del2317.29
Non-F508 mutation patients64.51
One determined mutation64.51
Unexamined118.27
  • Mean BMI Z-score: ± SD.

  • >18 years old

  • <18 years old

  • −1.2

  • −0.7

Mean FEV1 (% predicted)89.7
Chronic S.aureus3929.32
Chronic P.aeruginosae3324.8
CF liver disease5440.60
CF-related diabetes64.51
Pancreatic sufficient cases32.2

* Note data from ECFSPR 2019

Table 3.

Allele frequencies in 122 Albanian patients and Classes according to their effect on the synthesis and/or function of the CFTR protein.

CFTR gene mutations NM_00492.3 Legacy name, coding DNA, protein nameMutation TypeClass of MutationAll Alleles N= 244(%)
F508del, c.1521_1523delCTT, p. Phe508deldeletionII203(83.19)
621+1G>T, c.489+1G>TsplicingI6 (2.45)
E822X, c.2464G>T, p. Glu822TernonsenseI5 (2.04)
G85E, c.254G>A, p. Gly85GlumissenseII5 (2.04)
G542X (c.1624G>T) p. Gly542TernonsenseI4 (1.63)
R1066C, c.3196C>T, p. Arg1066CysmissenseII3 (1.22)
**R1070Q, c.3209G>A, p. Arg1070GlnmissenseUnclassified3 (1.22)
R1158X, c.3472C>T, p. Arg1158TernonsenseI2 (0.81)
G1349D, c.4046G>A p. Gly1349AspmissenseIII2 (0.81)
N1303K, (c.3909C>G), p. Asn1303LysmissenseII2 (0.81)
**S466X, c.1397C>G, p. Ser466TernonsenseI2 (0.81)
1811+1G->C, c.1679+1G>CsplicingV1 (0.40)
E831X, c.2491G>T, p. Glu831XnonsenseI1 (0.40)
CFTRdele2-3(21kb), c.54-5940_273 + 10250 del, p. Ser18Argfs*16deletionI1 (0.40)

The new mutations for the Albanian population detected by University Hospital Motol are bolded.

** 2.0 complex alleles S466X-R1070Q

N: number of alleles; %: percentage rounded up to max. 2 digits after the full stop (thus may not add up exactly to 100%).

HGVS – Human Genome Variation Society nomenclature (www.hgvs.org/mutnomen/);

Legacy nomenclature according to the Cystic Fibrosis Mutation Database (www.genet.sickkids.on.ca/app)

Table 4.

Genotype variants and their frequency

Genotype variantsFrequency number (N=)Percentage %
F508del/F508del8775.00
F508del/non F508del2319.82
F508del/G85E43.44
F508del/E822X32.58
F508del/621+1G>T32.58
F508del/R1066C32.58
F508del/G1349D21.72
F508del/G542X21.72
F508del/N1303K21.72
F508del/R1070Q10.86
F508del/S466X-R1070Q - in cis10.86
F508del/R1158X10.86
F508del /E831X10.86
non F508del/non F508del65.17
G542X/621+1G>T10.86
G85E/R1158X10.86
G542X/E822X10.86
621+1G>T/621+1G>T10.86
CFTR dele 2.3/1811+1G->C10.86
S466X-R1070Q in cis / E822X10.86

[i] N: number of genotypes; %: percentage rounded up to max. 2 digits after the full stop (thus may not add up exactly to 100%).

DOI: https://doi.org/10.2478/bjmg-2024-0004 | Journal eISSN: 2199-5761 (formerly 1311-0160) | Journal ISSN: 1311-0160
Language: English
Page range: 31 - 36
Published on: Sep 6, 2024
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services

© 2024 I Kasmi, G Kasmi, B Basholli, HS Sefa, E Vevecka, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.